KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Change in Cash (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Change in Cash for 16 consecutive years, with $3.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Cash fell 95.0% to $3.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$62.3 million, a 204.0% decrease, with the full-year FY2025 number at -$62.3 million, down 204.0% from a year prior.
  • Change in Cash was $3.6 million for Q4 2025 at Biolife Solutions, up from -$2.4 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $71.2 million in Q4 2024 to a low of -$35.3 million in Q2 2022.
  • A 5-year average of -$2.9 million and a median of -$2.3 million in 2023 define the central range for Change in Cash.
  • Peak YoY movement for Change in Cash: plummeted 2797.92% in 2021, then soared 407.94% in 2022.
  • Biolife Solutions' Change in Cash stood at -$5.4 million in 2021, then crashed by 41.34% to -$7.7 million in 2022, then skyrocketed by 310.25% to $16.1 million in 2023, then skyrocketed by 341.96% to $71.2 million in 2024, then plummeted by 95.0% to $3.6 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Change in Cash are $3.6 million (Q4 2025), -$2.4 million (Q3 2025), and -$35.0 million (Q2 2025).